| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |